Keeping Current

Sep 29, 2023

Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF).
  
Credit available for this activity expires: 9/29/2024
Earn Credit / Learning...

Sep 29, 2023

Expert tips to better select treatments, implement, and talk with patients.
  
Credit available for this activity expires: 9/29/2024
Earn Credit / Learning Objectives & Disclosures:

Sep 29, 2023

Do you know about the extra cardiac effects and other effects of angiotensin receptor-neprilysin inhibitors (ARNIs)?
  
Credit available for this activity expires: 9/29/2024
Earn Credit / Learning Objectives & Disclosures:

Sep 29, 2023

Do you know what the challenges are for patients and clinicians when managing C3 glomerulopathy, and what the role of emerging therapies is?

Credit available for this activity expires: 9/28/24
Earn Credit / Learning Objectives & Disclosures:

Sep 28, 2023

How up to date is your knowledge of ongoing clinical trials in breast cancer? Ready to absorb new data releases at upcoming Autumn meetings?

Credit available for this activity expires: 9/27/24
Earn Credit / Learning Objectives & Disclosures: